Depot-specific differences in adipose tissue gene expression in lean and obese subjects

Diabetes

Volumn 47, Issue 1, 1998, Pages 98-103

  Lefebvre, Anne Marie ^a   Laville, Martine ^b   Vega, Nathalie ^b   Riou, Jean Paul ^b   Van Gaal, Luc ^c   Auwerx, Johan ^a   Vidal, Hubert ^b  

^a INSTITUT PASTEUR DE LILLE   (France)

^b INSERM   (France)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; INSULIN RECEPTOR; LIPOPROTEIN LIPASE; MESSENGER RNA; PEROXISOME PROLIFERATOR; TRIACYLGLYCEROL LIPASE;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; EXON; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOLECULAR DYNAMICS; OBESITY; PRIORITY JOURNAL; RECEPTOR BINDING; RNA SPLICING; SUBCUTANEOUS FAT DISORDER;

EID: 0031964987     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.47.1.98     Document Type: Article

References (37)

1. Björntorp P: Metabolic implication of body fat distribution. Diabetes Care 14:1132-1143, 1991
2. Emery EM, Schmid TL, Kahn HS, Filozof PP: A review of the association between abdominal fat distribution, health outcome measures, and modifiable risk factors. Am J Health Promot 7:342-353, 1993
3. Björntorp P: "Portal" adipose tissue as a generator of risk factor for cardiovascular disease and diabetes. Arteriosclerosis 10:493-496, 1990
4. Flier JS: The adipocyte: storage depot or node on the energy information superhighway? Cell 80:15-18, 1995
5. Shimomura I, Funahashi T, Takahashi M, Maeda K, Konati K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, Matsuzawa Y: Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 2:800-803, 1996
6. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I: Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46:860-867, 1997
7. Zhang Y, Proenca R, Maffaei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature (Lond) 372:425-432, 1994
8. Hube F, Lietz U, Igel M, Jensen PB, Tornqvist H, Joost HG, Hauner H: Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. Horm Metab Res 28:690-693, 1996
9. Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S: Depot- and sex-specific differences in human leptin mRNA expression: implication for the control of regional fat distribution. Diabetes 46:342-347, 1997
10. Östman J, Arner P, Engfeldt P, Kager L: Regional differences in the control of lipolysis in human adipose tissue. Metabolism 28:1198-1205, 1979
11. Engjeldt P, Arner P: Lipolysis in human adipocytes, effects of cell size, age and of regional differences. Horm Metab Res 19:26-29, 1988
12. Bolinder J, Kager L, Östman J, Arner P: Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 32:117-123, 1983
13. Schoonjans K, Staels B, Auwerx J: The peroxisome proliferator activated receptor and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1302:93-109, 1996
14. Auboeuf D, Rieusset J, Fajas L, Vallier P, Frering V, Riou JP, Staels B, Auwerx J, Laville M, Vidal H: Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptor and liver X receptorγ in humans: no alteration in adipose tissue of obese and NIDDM patients. Diabetes 46:1319-1327, 1997
15. Auboeuf D, Vidal H: The use of the reverse transcription-competitive polymerase chain reaction to investigate the in vivo regulation of gene expression in small tissue samples. Anal Biochem 245:141-148, 1997
16. Vidal H, Auboeuf D, De Vos P, Staels B, Riou JP, Auwerx J, Laville M: The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. J Clin Invest 98:251-255, 1996
17. Laville M, Auboeuf D, Khalfallah Y, Vega N, Riou JP, Vidal H: Acute regulation by insulin of phosphatidylinositol-3-kinase, Rad, GLUT4 and lipoprotein lipase mRNA levels in human muscle. J Clin Invest 98:43-49, 1996
18. Fajas L, Auboeuf D, Raspé E, Schoonjans K, Lefebvre A-M, Saladin R, Najib J, Laville M, Fruchart J-C, Deeb S, Puig-Vidal A, Flier J, Briggs MR, Staels B, Vidal H, Auwerx J: The organization, promoter analysis, and expression of the human PPAR-γ gene. J Biol Chem 272:18779-18789, 1997
19. Vague J: Les obésités: études biométriques. Biol Med (Paris) 36:1-7, 1947
20. Mauriège P, Marette A, Atgié C, Bouchard C, Thériault G, Bukowiecki LK, Marceau P, Biron S, Nadeau A, Després J-P: Regional variation in adipose tissue metabolism of severely obese premenopausal women. J Lipid Res 36:672-684, 1995
21. Hoffstedt J, Wahrenberg H, Thörne A, Lönnqvist F: The metabolic syndrome is related to β3-adrenoceptor sensitivity in visceral adipose tissue. Diabetologia 39:838-844, 1996
22. Livingston JN, Lerea KM, Bolinder J, Kager L, Backman L, Arner P: Binding and molecular weight properties of the insulin receptor from omental and subcutaneous adipocytes in human obesity. Diabetologia 27:447-453, 1984
23. Kosaki A, Pillay TS, Xu L, Webster NJG: The B isoform of the insulin receptor signals more efficiently than the A isoform in HepG2 cells. J Biol Chem 270:20816-20823, 1995
24. Okabayashi Y, Maddux BA, McDonald AR, Logson CD, Williams JA, Goldfine ID: Mechanism of insulin-induced insulin receptor downregulation: decrease of receptor biosynthesis and mRNA levels. Diabetes 38:182-187, 1989
25. Wiersma MM, Auboeuf D, Nieuwenhuizen-Bakker I, Radder JK, Riou JP, Vidal H: Insulin receptor mRNA splicing and altered metabolic control in aged and mildly insulin-deficient rats. Amer J Physiol 272:E607-E615, 1997
26. Arner P: Metabolism of fatty acids: an overview. In Obesity, Toward a Molecular Approach. Bray GA, Ricquier D, Speigelman B, Eds. New York, Allan Liss, 1990, p. 159-172
27. DiGirolamo M, Newby FG, Lovejoy J: Lactate production in adipose tissue: a regulated function with extra-adipose implications. FASEB J 6:2405-2412, 1992
28. Marette A, Mauriège P, Marcotte B, Atgié C, Bouchard C, Thériault G, Buckowiecki LJ, Marceau P, Biron S, Nadeau A, Després J-P: Regional variation in adipose tissue insulin action and GLUT4 glucose transporter expression in severely obese premenopausal women. Diabetologia 40:590-598, 1997
29. Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, Staels B, Auwerx J: Transient increase in obese gene expression after food intake and insulin administration. Nature (Lond) 377:527-529, 1995
30. Considine RV, Considine EL, Williams CJ, Nyce MR, Magosin SA, Bauer TL, Rosato EL, Colberg J, Caro JF: Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest 95:2986-2988, 1995
31. Ciaraldi TP, Molina JM, Olefsky JM: Insulin action kinetics in adipocytes from obese and noninsulin-dependent diabetes mellitus subjects: identification of multiple cellular defects in glucose transport. J Clin Endocrinol Metab 72:876-882, 1991
32. Wahli W, Braissant O, Desvergne B: PPARs: a nuclear receptor signaling pathway in lipid metabolism. Annu Rev Cell Dev Biol 12:335-363, 1996
33. Spiegelman BM, Flier JS: Adipogenesis and obesity: rounding out the big picture. Cell 87:377-380, 1096
34. 12-14 -prostaglandin J2 is a ligand for the adipocyte determination factor PPAR-γ Cell 82:803-812, 1995
35. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM: A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83:813-819, 1995
36. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ. J Biol Chem 270:12953-12956, 1995
37. Schoonjans K, Martin G, Staels B, Auwerx J: Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr Opin Lipidol 8:159-166, 1997